These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27259861)
1. Immunotherapy for Lung Cancer. Reinmuth N; Reck M Oncol Res Treat; 2016; 39(6):360-8. PubMed ID: 27259861 [TBL] [Abstract][Full Text] [Related]
2. Advances in Cancer Therapy: Immunotherapies. Marmé D Oncol Res Treat; 2016; 39(6):324-5. PubMed ID: 27260772 [No Abstract] [Full Text] [Related]
3. Immunotherapy of Melanoma. Bender C; Hassel JC; Enk A Oncol Res Treat; 2016; 39(6):369-76. PubMed ID: 27259558 [TBL] [Abstract][Full Text] [Related]
4. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma. Grünwald V Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695 [TBL] [Abstract][Full Text] [Related]
6. [Non-small cell lung cancer: news from immunotherapy]. Reinmuth N; Heigener DF; Reck M Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in Breast Cancer. Marmé F Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of Brain Cancer. Roth P; Preusser M; Weller M Oncol Res Treat; 2016; 39(6):326-34. PubMed ID: 27260656 [TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy in lung cancer: New concepts]. Goubet AG; Livartowski A; Romano E Rev Mal Respir; 2018 Jun; 35(6):642-651. PubMed ID: 29941206 [TBL] [Abstract][Full Text] [Related]
10. Targeting the immune system in the treatment of non-small-cell lung cancer. Rangachari D; Brahmer JR Curr Treat Options Oncol; 2013 Dec; 14(4):580-94. PubMed ID: 23934510 [TBL] [Abstract][Full Text] [Related]
11. Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer. Heigener D; Reck M Expert Rev Anticancer Ther; 2015 Jan; 15(1):69-83. PubMed ID: 25199617 [TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer. Yang J; Chen J; Wei J; Liu X; Cho WC Expert Opin Biol Ther; 2016 Oct; 16(10):1209-23. PubMed ID: 27426430 [TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer. Anagnostou VK; Brahmer JR Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707 [TBL] [Abstract][Full Text] [Related]
14. Harnessing the immune system for the treatment of non-small-cell lung cancer. Brahmer JR J Clin Oncol; 2013 Mar; 31(8):1021-8. PubMed ID: 23401435 [TBL] [Abstract][Full Text] [Related]
15. Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer. Garon EB Semin Oncol; 2015 Oct; 42 Suppl 2():S11-8. PubMed ID: 26477470 [TBL] [Abstract][Full Text] [Related]
16. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction. Socinski MA Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469 [No Abstract] [Full Text] [Related]
17. Targeting the immune system to treat lung cancer: rationale and clinical experience. Guibert N; Delaunay M; Mazières J Ther Adv Respir Dis; 2015 Jun; 9(3):105-20. PubMed ID: 25827132 [TBL] [Abstract][Full Text] [Related]
18. Advances in Cancer Therapy: Targeted Therapies. Marmé D Oncol Res Treat; 2016; 39(12):758-759. PubMed ID: 27889783 [No Abstract] [Full Text] [Related]